🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Lacosamide - Medicines in Ireland

30 authorised products containing Lacosamide, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
Showing 30 authorised medicines
MedicineActive substanceLicence holderStatus
10 mg/ml Solution for infusion
EU/1/19/1383/001-002
Lacosamide UCB Pharma S.A.
Lacosamide Accord 10 mg/ml solution for infusion
EU/1/17/1230/026-027
Lacosamide Accord Healthcare S.L.U.
Lacosamide Accord 100 mg film coated tablets
EU/1/17/1230/005-008
Lacosamide Accord Healthcare S.L.U.
Lacosamide Accord 150 mg film coated tablets
EU/1/17/1230/009-012
Lacosamide Accord Healthcare S.L.U.
Lacosamide Accord 200 mg film coated tablets
EU/1/17/1230/013-016
Lacosamide Accord Healthcare S.L.U.
Lacosamide Accord 50 mg film coated tablets
EU/1/17/1230/001-004
Lacosamide Accord Healthcare S.L.U.
Lacosamide Adroiq 10 mg/ml solution for infusion
EU/1/23/1732/001
Lacosamide Extrovis EU Kft.
Lacosamide Ascend 10 mg/ml syrup
PA23429/001/001
Lacosamide Ascend GmbH Not marketed
Lacosamide Fresenius Kabi 10 mg/ml solution for infusion
PA2059/078/001
Lacosamide Fresenius Kabi Deutschland GmbH Not marketed
Lacosamide Grindeks 100 mg film-coated tablets
PA22992/026/002
Lacosamide AS Grindeks Not marketed
Lacosamide Grindeks 150 mg film-coated tablets
PA22992/026/003
Lacosamide AS Grindeks Not marketed
Lacosamide Grindeks 200 mg film-coated tablets
PA22992/026/004
Lacosamide AS Grindeks Not marketed
Lacosamide Grindeks 50 mg film-coated tablets
PA22992/026/001
Lacosamide AS Grindeks Not marketed
Lacosamide Krka 100 mg film-coated tablets
PA1347/099/002
Lacosamide KRKA, d.d., Novo mesto Marketed
Lacosamide Krka 150 mg film-coated tablets
PA1347/099/003
Lacosamide KRKA, d.d., Novo mesto Marketed
Lacosamide Krka 200 mg film-coated tablets
PA1347/099/004
Lacosamide KRKA, d.d., Novo mesto Marketed
Lacosamide Krka 50 mg film-coated tablets
PA1347/099/001
Lacosamide KRKA, d.d., Novo mesto Marketed
Lacosamide UCB 10 mg/ml Syrup
EU/1/19/1383/003
Lacosamide UCB Pharma S.A.
Lacosamide UCB 100 mg Film-coated tablet
EU/1/19/1383/010-015
Lacosamide UCB Pharma S.A.
Lacosamide UCB 150 mg Film-coated tablet
EU/1/19/1383/016-021
Lacosamide UCB Pharma S.A.
Lacosamide UCB 200 mg Film-coated tablet
EU/1/19/1383/022-027
Lacosamide UCB Pharma S.A.
Lacosamide UCB 50 mg Film-coated tablet
EU/1/19/1383/004-009
Lacosamide UCB Pharma S.A.
Vimpat 10 mg/ml solution for infusion
EU/1/08/470/16
Lacosamide UCB Pharma S.A.
Vimpat 10 mg/ml syrup
EU/1/08/470/018-019
Lacosamide UCB Pharma S.A.
Vimpat 100 mg film-coated tablets
EU/1/08/470/4-6
Lacosamide UCB Pharma S.A.
Vimpat 15 mg/ml syrup
EU/1/08/470/14-15
Lacosamide UCB Pharma S.A.
Vimpat 150 mg film-coated tablets
EU/1/08/470/7-9
Lacosamide UCB Pharma S.A.
Vimpat 200 mg film-coated tablets
EU/1/08/470/10-12
Lacosamide UCB Pharma S.A.
Vimpat 50 mg film-coated tablets
EU/1/08/470/1-3
Lacosamide UCB Pharma S.A.
Vimpat 50mg/ 100mg/ 150mg film-coated tablets
EU/1/08/470/13
Lacosamide UCB Pharma S.A.
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.